Lance Wilkes analyst BERNSTEIN

Currently out of the existing stock ratings of Lance Wilkes, 40 are a BUY (71.43%), 16 are a HOLD (28.57%).

Lance Wilkes

Work Performance Price Targets & Ratings Chart

Analyst Lance Wilkes, currently employed at BERNSTEIN, carries an average stock price target met ratio of 58.32% that have a potential upside of 28.64% achieved within 352 days.

Lance Wilkes’s has documented 118 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CNC, Centene Corp at 21-Nov-2025.

Wall Street Analyst Lance Wilkes

Analyst best performing recommendations are on AGL (AGILON HEALTH).
The best stock recommendation documented was for CNC (CENTENE CORP) at 9/5/2025. The price target of $36 was fulfilled within 27 days with a profit of $7.02 (24.22%) receiving and performance score of 8.97.

Average potential price target upside

ANTM Anthem CI Cigna Corp HUM Humana UNH UnitedHealth Group CNC Centene Corp CVS CVS Health Corp HCA HCA Holdings OSH Oak Street Health ELV Elevance Health AGL agilon health MOH Molina Healthcare

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$533

$50.42 (10.45%)

$617

3 years 5 months 21 days ago
(22-Jun-2022)

2/4 (50%)

$67.25 (14.44%)

125

Buy

$550

$67.42 (13.97%)

$430

3 years 5 months 27 days ago
(16-Jun-2022)

1/2 (50%)

$95.24 (20.94%)

108

Buy

$596

$113.42 (23.50%)

$574

3 years 6 months 16 days ago
(27-May-2022)

3/5 (60%)

$76.79 (14.79%)

741

Buy

$580

$97.42 (20.19%)

$586

3 years 6 months 19 days ago
(25-May-2022)

4/6 (66.67%)

$67.58 (15.14%)

149

Buy

$545

$62.42 (12.93%)

3 years 7 months 9 days ago
(04-May-2022)

6/7 (85.71%)

$36.02 (7.08%)

40

Show more analysts

Please expand the browser size to see the chart

Which stock is Lance Wilkes is most bullish on?

Potential upside of $110.23 has been obtained for UNH (UNITEDHEALTH GROUP)

Which stock is Lance Wilkes is most reserved on?

Potential downside of -$3.36 has been obtained for CVS (CVS HEALTH CORP)

What Year was the first public recommendation made by Lance Wilkes?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?